| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/22/1998 | CA2257823A1 Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences |
| 01/22/1998 | CA2257822A1 Infectious papillomavirus pseudoviral particles |
| 01/22/1998 | CA2257383A1 Recombinant kynurenine-3-hydroxylase enzyme and process for its preparation |
| 01/21/1998 | EP0819763A1 Engineered acarid allergen and process for producing the same |
| 01/21/1998 | EP0819757A2 Enzyme which activates an interferon-gamma inducing polypeptide |
| 01/21/1998 | EP0819700A1 Extraction of myelin basic protein |
| 01/21/1998 | EP0819699A1 A process for producing a glycosylated amino compound |
| 01/21/1998 | EP0819177A1 Expression library immunization |
| 01/21/1998 | EP0819176A1 Transgenic plants exhibiting heterologous virus resistance |
| 01/21/1998 | EP0819174A1 Plant pathogen resistance genes and uses thereof |
| 01/21/1998 | EP0819173A1 Mutant of the erythrina caffra type inhibitor and the use of the said mutant for purifying serin proteases |
| 01/21/1998 | EP0819172A1 Polynucleotide immunogenic agents |
| 01/21/1998 | EP0819171A1 Antibodies for the detection of hla-g |
| 01/21/1998 | EP0819170A1 Retroviral vectors |
| 01/21/1998 | EP0819169A1 Methods for screening compounds for estrogenic activity |
| 01/21/1998 | EP0819168A1 Human tumor necrosis factor receptor |
| 01/21/1998 | EP0819167A2 Dna encoding galanin galr2 receptors and uses thereof |
| 01/21/1998 | EP0819137A1 Peptides with growth promotion properties |
| 01/21/1998 | EP0819010A1 Protein formulation comprising coagulation factor viii or factor ix in an aqueous solution |
| 01/21/1998 | EP0804609A4 NOVEL p53 RESPONSE GENES |
| 01/21/1998 | EP0701612B1 IMMUNOGENIC FORMULATION OF OspC ANTIGEN VACCINES FOR THE PREVENTION AND TREATMENT OF LYME DISEASE AND RECOMBINANT METHODS FOR THE PREPARATION OF SUCH ANTIGENS |
| 01/21/1998 | EP0527806B1 Epithelins: novel cysteine - rich growth modulating proteins |
| 01/21/1998 | EP0504363B1 PURIFIED IgG ANTIBODIES |
| 01/21/1998 | CN1171134A Production of variant nisin |
| 01/21/1998 | CN1171133A Gene participating in apoptosis |
| 01/21/1998 | CN1171119A Binding agents for curing inflammatory, autoimmune or allergic diseases |
| 01/21/1998 | CN1171118A Fibronectin adhesion inhibitors |
| 01/21/1998 | CN1171117A Use of MHC-II binding and/or MHC-II minicking molecules for prevention and/or treatment of inflammatory diseases |
| 01/21/1998 | CN1171113A Mutants of Rb and p53 genes and uses thereof |
| 01/21/1998 | CN1170875A Diagnostic agent for hepatitis C virus infection disease |
| 01/21/1998 | CN1170760A Improvements in sustainable cell line for production of Marek's Disease Vaccines |
| 01/21/1998 | CN1037103C Nevol process for preparing biologically active proteins from human urine |
| 01/20/1998 | US5710266 Nucleic acid encoding an interleukin 4 signal transducer |
| 01/20/1998 | US5710265 Genetic engineering; polypeptides |
| 01/20/1998 | US5710262 Nucleic acid encoding HB15 polypeptides |
| 01/20/1998 | US5710257 Method of causing selective immunosuppression using HL-60-related lectins |
| 01/20/1998 | US5710256 Methadone derivatives and protein and polypeptide methadone derivative conjugates and labels |
| 01/20/1998 | US5710255 Characterization of a novel anti-p110RB monoclonal antibody |
| 01/20/1998 | US5710254 Purification of von Willebrand factor by affinity chromatography |
| 01/20/1998 | US5710253 Method for decoloring human serum albumin |
| 01/20/1998 | US5710252 Genetic engineering and polypeptides |
| 01/20/1998 | US5710251 Ion exchanging with anions and cations and applying hydroxyapatite chromatography |
| 01/20/1998 | US5710250 Encoded by specific sequences of nucleotides hybridizing under strngent conditions; diagnosis of autoimmune diseases |
| 01/20/1998 | US5710248 Chimeric proteins |
| 01/20/1998 | US5710245 Alpha-helix mimetics and methods relating thereto |
| 01/20/1998 | US5710244 Derivatized calcitonins |
| 01/20/1998 | US5710131 Protein isolated from extract of hirudo medicinalis (leech) |
| 01/20/1998 | US5710129 Inhibitors of SH2-mediated processes |
| 01/20/1998 | US5710128 Pharmaceutical compositions of lipopolysaccharide-binding polypeptides |
| 01/20/1998 | US5710126 T cell epitopes of ryegrass pollen allergen |
| 01/20/1998 | US5710123 Peptide inhibitors of selectin binding |
| 01/20/1998 | US5710044 Plasmid for expressing phosphorylated recombinant proteins in a bacterial system |
| 01/20/1998 | US5710038 Primary cultures of normal and tumoral human ovarian epithelium |
| 01/20/1998 | US5710037 Retroviral vector particles |
| 01/20/1998 | US5710032 Secondary-metabolite biosynthesis genes from actinomycetes, method of isolating them and their use |
| 01/20/1998 | US5710031 Genomic DNA encoding a Pseudomonas global transcriptional activation element and its use in activating gene expression |
| 01/20/1998 | US5710028 Method of quick screening and identification of specific DNA sequences by single nucleotide primer extension and kits therefor |
| 01/20/1998 | US5710027 Process and vector for expressing alpha-interferon in E. coli |
| 01/20/1998 | US5710026 Cytoplasmic antiproteinase-2 and cytoplasmic antiproteinase-3 and coding sequences |
| 01/20/1998 | US5710025 Cell-type specific transcription factor |
| 01/20/1998 | US5710024 Polynucleotides that encode the calcitonin gene-related peptide receptor coponent factor (HOUNDC44) |
| 01/20/1998 | US5710023 Isolated polynucleotide sequence; genetic engineering |
| 01/20/1998 | US5710022 Nuclear mitotic phosphoprotein |
| 01/20/1998 | US5710020 Producing insecticidal protein |
| 01/20/1998 | US5710019 Human potassium channel 1 and 2 proteins |
| 01/20/1998 | US5710018 Mammalian influx peptide transporter |
| 01/20/1998 | US5710017 DNA encoding a constitutive activator retinoic acid response (CAR) receptor |
| 01/20/1998 | US5710013 Isolated nucleic acid encoding a polyeptide with specified amino acid sequence; medical diagnosis |
| 01/20/1998 | US5710010 Assays for the presence of a mutant EGF receptor |
| 01/20/1998 | US5710004 Methods of using novel steroid hormone orphan receptors |
| 01/20/1998 | US5710003 Diagnostic test to determine the malignancy of smooth muscle tumors |
| 01/20/1998 | US5710002 Detection of Clavibacter michiganensis subsp. sepedonicus |
| 01/20/1998 | US5710001 17q-linked breast and ovarian cancer susceptibility gene |
| 01/20/1998 | US5709999 Germline mutation of human breast and ovarian cancer predisposing gene |
| 01/20/1998 | US5709996 Self-assembling recombinant papillomavirus capsid proteins |
| 01/20/1998 | US5709995 Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses |
| 01/20/1998 | US5709865 Immunogenic composition against Bovine Viral Diarrhea Virus II glycoprotein 53 (BVDV-II gp53) |
| 01/20/1998 | US5709862 Immunology and antigens |
| 01/20/1998 | US5709861 Compositions for the delivery of antigens |
| 01/20/1998 | US5709860 Induction of cytotoxic T-lymphocyte responses |
| 01/20/1998 | US5709859 Complexes of fusion proteins; antitumor agent; antiinflammatory agents |
| 01/20/1998 | US5709858 To which they are capable of binding; specified amino acid sequences; medical diagnosis |
| 01/20/1998 | US5709844 Transgenic mice expressing HPV early region oncogene develop progressive cervico-vaginal neoplasia |
| 01/20/1998 | CA1339631C Process and intermediates for grf peptide |
| 01/18/1998 | CA2181418A1 Transgenes with floury2 gene signal peptide |
| 01/15/1998 | WO1998001757A1 Labelling and selection of molecules |
| 01/15/1998 | WO1998001755A1 Screening method for mena protein involved in microfilament dynamics |
| 01/15/1998 | WO1998001754A1 Novel proteins within the type e botulinum neurotoxin complex |
| 01/15/1998 | WO1998001740A2 Diagnosis of williams syndrome and williams syndrome cognitive profile by analysis of a lim-kinase gene |
| 01/15/1998 | WO1998001570A2 Mutated antibody-dependent infection enhancing domains of hiv |
| 01/15/1998 | WO1998001564A1 Hiv envelope polypeptides and vaccine |
| 01/15/1998 | WO1998001563A2 Adenovirus e4 proteins for inducing cell death |
| 01/15/1998 | WO1998001562A1 Thermostable mutl genes and proteins and uses therefor |
| 01/15/1998 | WO1998001561A1 SUBUNIT VACCINE FOR $i(STREPTOCOCCUS EQUI) |
| 01/15/1998 | WO1998001560A1 Modified protein g and fragments thereof |
| 01/15/1998 | WO1998001559A1 Genes encoding mycobacterial proteins associated with cell binding and cell entry and uses thereof |
| 01/15/1998 | WO1998001558A2 Protein and peptide vaccines for inducing mucosal immunity |
| 01/15/1998 | WO1998001557A2 Mammalian chemokine reagents |
| 01/15/1998 | WO1998001556A1 A lysosomal-associated multispanning membrane protein, laptm5 and a nucleic acid encoding laptm5 |
| 01/15/1998 | WO1998001555A2 Truncated soluble tumor necrosis factor type-i and type-ii receptors |